Alto Neuroscience (ANRO) is down -61.5%, or -$8.94 to $5.59.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANRO:
- Alto Neuroscience falls -62.8%
- Morning Movers: AT&T rises and Coca-Cola falls following quarterly reports
- Wedbush downgrades Alto Neuroscience to Neutral following ALTO-100 readout
- Alto Neuroscience downgraded to Neutral from Outperform at Wedbush
- Alto Neuroscience downgraded to Neutral from Buy at Rodman & Renshaw